It is hard to get excited after looking at Telekom Malaysia Berhad's (KLSE:TM) recent performance, when its stock ...

KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

We recently published a list of 10 Most Profitable Large Cap Stocks to Buy Now. In this article, we are going to take a look ...

LAS VEGAS, March 13, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives Inc. (OTC: BDPT) today announced the successful completion of dosage trials for its innovative weight loss product, Zeranovia™.

Record full year 2024 net sales of $25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx ...

Jones Financial Companies Lllp grew its holdings in Toyota Motor Co. (NYSE:TM – Free Report) by 63.4% during the 4th quarter, ...

Arizona continues to be one of our most mature and strongest platforms within the Ensign family and we are so pleased that we were able to further strengthen our presence in the greater Phoenix area,” ...

The board of Telekom Malaysia Berhad (KLSE:TM) has announced that it will be paying its dividend of MYR0.185 on the 28th of March, an increased payment from last year's comparable dividend.

Settlement and handover related to the purchase by Landsbankinn of TM tryggingar hf. from Kvika Bank took place today and Landsbankinn has assumed operation of the company. TM will be operated as a ...